Effects on plasma endotoxin and eicosanoid concentrations and serum cytokine activities in horses competing in a 48-, 83-, or 159-km endurance ride under similar terrain and weather conditions

被引:19
作者
Barton, MH [1 ]
Williamson, L
Jacks, S
Norton, N
机构
[1] Univ Georgia, Coll Vet Med, Athens, GA 30602 USA
[2] Univ Georgia, Dept Large Anim Med, Athens, GA 30602 USA
[3] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA
关键词
D O I
10.2460/ajvr.2003.64.754
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective-To determine plasma endotoxin concentration in horses competing in a 48-, 83-, or 159-km endurance race and its importance with regard to physical, hematologic, or serum and plasma biochemical variables. Animals-83 horses. Procedure-Weight and rectal temperature measurements and blood samples were obtained before, during, and after exercise. Blood samples were analyzed for plasma endotoxin concentration; serum antiendotoxin antibody titers; thromboxane B-2 (TxB(2)) and 6-keto-prostaglandin F-1alpha (PGF(1alpha)) concentrations; tumor necrosis factor alpha (TNFalpha) and interleukin-6 (IL-6) activities; WBC, plasma protein, lactate, serum electrolyte, and calcium concentrations; PCV; and creatine kinase activity. Results-Detection of plasma endotoxin increased during exercise for horses competing at all distances but occurred more frequently in the 48- and 83-km groups. Plasma lactate concentration was significantly greater when endotoxin was concurrently detected. Endotoxin in plasma was not significantly associated with success of race completion. Plasma TxB(2) and PGF(1alpha) concentrations and serum IL-6 activity significantly increased with exercise. Horses that had an excellent fitness level (as perceived by their owners) had greater decreases in serum antiendotoxin antibody titers during exercise than did horses perceived as less fit. In horses with better finish times, TxB(2) and PGF(1alpha) concentrations were significantly greater and TNFalpha activity was significantly less than that of slower horses. Conclusions and Clinical Relevance-Endotoxemia developed during endurance racing, but was significantly correlated with increased plasma lactate concentration and not with other variables indicative of endotoxemia. Plasma TxB(2) and PGF(1alpha) concentrations and serum TNFalpha activity may be associated with performance success. (Am J Vet Res 2003;64:754-761)
引用
收藏
页码:754 / 761
页数:8
相关论文
共 36 条
[1]   EFFECTS OF CATECHOLAMINES ON EICOSANOID SYNTHESIS WITH SPECIAL REFERENCE TO PROSTANOID LEUKOTRIENE RATIO [J].
ALANKO, J ;
RIUTTA, A ;
VAPAATALO, H .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (06) :677-688
[2]  
BAKER B, 1988, J S AFR VET ASSOC, V59, P63
[3]   Body weight, hematologic findings, and serum and plasma biochemical findings of horses competing in a 48-, 83-, or 159-km endurance ride under similar terrain and weather conditions [J].
Barton, MH ;
Williamson, L ;
Jacks, S ;
Norton, N .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2003, 64 (06) :746-753
[4]   STRENUOUS EXERCISE CAUSES SYSTEMIC ENDOTOXEMIA [J].
BOSENBERG, AT ;
BROCKUTNE, JG ;
GAFFIN, SL ;
WELLS, MTB ;
BLAKE, GTW .
JOURNAL OF APPLIED PHYSIOLOGY, 1988, 65 (01) :106-108
[5]  
BROCKUTNE JG, 1988, S AFR MED J, V73, P533
[6]   Endotoxaemia, production of tumour necrosis factor α and polymorphonuclear neutrophil activation following strenuous exercise in humans [J].
Camus, G ;
Nys, M ;
Poortmans, JR ;
Venneman, I ;
Monfils, T ;
Deby-Dupont, G ;
Juchmès-Ferir, A ;
Deby, C ;
Lamy, M ;
Duchateau, J .
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY, 1998, 79 (01) :62-68
[7]   ARE SIMILAR INFLAMMATORY FACTORS INVOLVED IN STRENUOUS EXERCISE AND SEPSIS [J].
CAMUS, G ;
DEBYDUPONT, G ;
DUCHATEAU, J ;
DEBY, C ;
PINCEMAIL, J ;
LAMY, M .
INTENSIVE CARE MEDICINE, 1994, 20 (08) :602-610
[8]   Mild endotoxaemia and the inflammatory response induced by a marathon race [J].
Camus, G ;
Poortmans, J ;
Nys, M ;
DebyDupont, G ;
Duchateau, J ;
Deby, C ;
Lamy, M .
CLINICAL SCIENCE, 1997, 92 (04) :415-422
[9]  
CARGILE JL, 1995, AM J VET RES, V56, P1451
[10]   ADMINISTRATION OF A RECEPTOR ANTAGONIST FOR PLATELET-ACTIVATING-FACTOR DURING EQUINE ENDOTOXEMIA [J].
CARRICK, JB ;
MORRIS, DD ;
MOORE, JN .
EQUINE VETERINARY JOURNAL, 1993, 25 (02) :152-157